Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
ASML
ASML
$708B
| $2.77M | ﹤0.01% |
25,207
-103,078
| -80% | -$10.9M |
|
2002
Escalade
ESCA
$276M
| $2.76M | ﹤0.01% |
216,200
+13,964
| +7% | +$162K |
|
|
SGMO
2003
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.75M | ﹤0.01% |
594,500
+480,300
| +421% | +$2.44M |
|
2004
DXP Enterprises
DXPE
$3.12B
| $2.75M | ﹤0.01% |
97,600
-171,800
| -64% | -$3.96M |
|
2005
Energy Transfer Partners
ET
$72.5B
| $2.74M | ﹤0.01% |
163,352
-1,545,200
| -90% | -$26.1M |
|
2006
Pampa Energía
PAM
$4.23B
| $2.73M | ﹤0.01% |
84,400
-118,800
| -58% | -$3.31M |
|
2007
Tandem Diabetes Care
TNDM
$1.58B
| $2.73M | ﹤0.01% |
35,640
+6,210
| +21% | +$453K |
|
|
LBAI
2008
DELISTED
Lakeland Bancorp Inc
LBAI
| $2.72M | ﹤0.01% |
193,700
-62,402
| -24% | -$798K |
|
|
MBVT
2009
DELISTED
Merchants Bancshares Inc
MBVT
| $2.72M | ﹤0.01% |
83,900
+11,200
| +15% | +$362K |
|
|
FPRX
2010
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.71M | ﹤0.01% |
51,700
-69,600
| -57% | -$3.32M |
|
|
CVSA
2011
Covista Inc
CVSA
$4.49B
| $2.71M | ﹤0.01% |
117,300
+61,600
| +111% | +$1.38M |
|
2012
Crown Crafts
CRWS
$30.7M
| $2.71M | ﹤0.01% |
265,200
+10,800
| +4% | +$107K |
|
|
RDC
2013
DELISTED
Rowan Companies Plc
RDC
| $2.69M | ﹤0.01% |
177,800
-250,900
| -59% | -$3.67M |
|
|
GRP.U
2014
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $2.69M | ﹤0.01% |
87,900
-53,200
| -38% | -$1.65M |
|
2015
Bankwell Financial Group
BWFG
$543M
| $2.69M | ﹤0.01% |
113,500
+18,100
| +19% | +$409K |
|
2016
RB Global
RBA
$15.6B
| $2.69M | ﹤0.01% |
+76,600
| New | +$2.5M |
|
2017
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $2.67M | ﹤0.01% |
24,267
+16,300
| +205% | +$1.77M |
|
|
CXDC
2018
DELISTED
China XD Plastics Company Limited
CXDC
| $2.67M | ﹤0.01% |
604,400
+15,100
| +3% | +$69.7K |
|
|
BSMX
2019
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $2.67M | ﹤0.01% |
303,400
-588,300
| -66% | -$5.45M |
|
|
BGG
2020
DELISTED
Briggs & Stratton Corp.
BGG
| $2.67M | ﹤0.01% |
+143,000
| New | +$2.95M |
|
|
EXAC
2021
DELISTED
Exactech Inc
EXAC
| $2.67M | ﹤0.01% |
98,600
+8,500
| +9% | +$234K |
|
|
RLH
2022
DELISTED
Red Lions Hotel Corporation
RLH
| $2.65M | ﹤0.01% |
318,300
-34,700
| -10% | -$255K |
|
2023
Arbor Realty Trust
ABR
$950M
| $2.65M | ﹤0.01% |
357,500
+78,741
| +28% | +$583K |
|
2024
Trupanion
TRUP
$1.34B
| $2.65M | ﹤0.01% |
156,800
-25,500
| -14% | -$390K |
|
|
PPBI
2025
DELISTED
Pacific Premier Bancorp
PPBI
| $2.65M | ﹤0.01% |
100,100
-64,800
| -39% | -$1.68M |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.